Researcher.Life Logo

Assay and Drug Development Technologies : Impact Factor & More

eISSN: 1557-8127pISSN: 1540-658X

Key Metrics

CiteScore
2.7
H-Index
62
Impact Factor
< 5
SJR
Q3Drug Discovery
SNIP
0.56
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Assay and Drug Development Technologies

Assay and Drug Development Technologies Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher MARY ANN LIEBERT, INC
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2002
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Assay and Drug Development Technologies ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your researchless than 30 sec
Free Report

Recently Published Papers in Assay and Drug Development Technologies

Molecular Mechanism of μ-Opioid Receptor Activation.
  • 18 Apr 2026
  • Assay and drug development technologies
Tongnao Decoction Exerts a Treatment Effect on Ischemic Stroke by IL-6/PI3K/Akt/GSK-3β Pathway: Based on the Network Pharmacology and Molecular Docking.
  • 7 Apr 2026
  • Assay and drug development technologies
Computational Prediction and In Vitro Validation of Potential Molecular Targets Associated with Adverse Reactions of Antimicrobial Drugs in Neonates.
  • 1 Apr 2026
  • Assay and drug development technologies
Targeting Quorum Sensing LsrR Protein in E. coli: A Computational Approach to Screen the Plant Bioactive Compounds as Inhibitors of Biofilm Formation in Urinary Tract Infections.
  • 23 Mar 2026
  • Assay and drug development technologies
Formulation and Optimization of Chitosan-Based Flurbiprofen Nanoparticles for Ocular Delivery: A Design of Experiments Approach.
  • 14 Mar 2026
  • Assay and drug development technologies
A Nasal Hydrogel Combining Metformin and Curcumin for Potential Nose-to-Brain Therapy in Neurodegenerative Disorders.
  • 10 Mar 2026
  • Assay and drug development technologies
Molecular Mechanism of μ-Opioid Receptor Activation.
  • 18 Apr 2026
  • Assay and drug development technologies
Tongnao Decoction Exerts a Treatment Effect on Ischemic Stroke by IL-6/PI3K/Akt/GSK-3β Pathway: Based on the Network Pharmacology and Molecular Docking.
  • 7 Apr 2026
  • Assay and drug development technologies
Computational Prediction and In Vitro Validation of Potential Molecular Targets Associated with Adverse Reactions of Antimicrobial Drugs in Neonates.
  • 1 Apr 2026
  • Assay and drug development technologies
Targeting Quorum Sensing LsrR Protein in E. coli: A Computational Approach to Screen the Plant Bioactive Compounds as Inhibitors of Biofilm Formation in Urinary Tract Infections.
  • 23 Mar 2026
  • Assay and drug development technologies
Formulation and Optimization of Chitosan-Based Flurbiprofen Nanoparticles for Ocular Delivery: A Design of Experiments Approach.
  • 14 Mar 2026
  • Assay and drug development technologies
A Nasal Hydrogel Combining Metformin and Curcumin for Potential Nose-to-Brain Therapy in Neurodegenerative Disorders.
  • 10 Mar 2026
  • Assay and drug development technologies
View all papers for this journal

FAQs on Assay and Drug Development Technologies

Global Journal Library:

Editage Plus logo

Cactus Communications Services Pte Ltd
20 McCallum Street, #19-01, Tokio Marine Centre, Singapore 069046

We are with you every step of the way as you achieve your dreams - publication, everything that precedes it, and everything that comes after. You are much more than your last research project. It’s time you got more.

Instagram icon

USEFUL LINKS

EXCITED ABOUT RESEARCHER.LIFE?

We are always looking for inspiration, feedback, and collaborators

Write to us

Copyright 2026 Cactus Communications. All rights reserved.

Privacy PolicyCookies PolicyTerms of UseCareers